سهم تغيير تاريخ
Acadia Pharmaceuticals USD 40.36M 68.31M 2026-09
Agios Pharmaceuticals USD 37.84M 2.09M 2026-09
Akebia Therapeutics USD 18.7M 5.68M 2026-09
Alnylam Pharmaceuticals USD 105.91M 8.8M 2026-09
Anika Therapeutics USD 28.56M 5.73M 2026-06
Arrowhead Research USD -173.08M 173.08M 2024-12
AstraZeneca USD 6.93B 362M 2026-06
Bristol-Myers Squibb USD 2.7B 33M 2026-09
Eli Lilly USD 18.19B 1.4B 2026-09
Halozyme Therapeutics USD 132.61M 4.52M 2026-09
Heron Therapeutics USD 54.57M 2.33M 2022-12
Insmed USD 163.95M 21.56M 2026-09
J&J USD 15.38B 233M 2026-09
Lexicon Pharmaceuticals USD 276K 5K 2026-03
Ligand Pharmaceuticals USD 14.51M 4.24M 2026-09
Merck USD 6.16B 43M 2026-09
Moderna USD 313M 33M 2026-09
Novartis USD 6.1B 182M 2026-09
Pfizer USD 10.02B 77M 2026-09
PTC Therapeutics USD 109.33M 17.98M 2026-09
Puma Biotechnology USD 9.48M 885K 2025-09
Sanofi EUR 24.12B 620M 2026-06
Takeda JPY 1.44T 6.17B 2026-09
Teva Pharmaceutical Industries USD 3.17B 48M 2026-09
Ultragenyx Pharmaceutical USD 59M 0 2026-09
Vanda Pharmaceuticals USD 1.85M 190K 2025-12
Veracyte USD 25.82M 3.16M 2026-09